Prothrombin G20210A (Factor II) Mutation

Assess your inherited risk of abnormal blood clotting with the Prothrombin G20210A (Factor II) Mutation test at Lucid Medical Diagnostics. This advanced molecular genetic test detects the Prothrombin G20210A mutation, an inherited genetic variant associated with an increased risk of deep vein thrombosis (DVT), pulmonary embolism, and other venous thromboembolic disorders. Using highly sensitive PCR-based molecular diagnostic technology, our experienced laboratory team provides accurate and reliable results to support diagnosis, risk assessment, treatment planning, and family screening. At Lucid Medical Diagnostics, we deliver timely, precise, and dependable genetic testing backed by advanced technology and expert diagnostic services for improved patient outcomes.

Home Sample Collection Available
Get Reports